X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Dr. Reddys - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DR. REDDYS LAB UNICHEM LAB/
DR. REDDYS LAB
 
P/E (TTM) x 32.5 34.1 95.3% View Chart
P/BV x 3.4 3.3 102.4% View Chart
Dividend Yield % 0.6 0.8 68.6%  

Financials

 UNICHEM LAB   DR. REDDYS LAB
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
DR. REDDYS LAB
Mar-17
UNICHEM LAB/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3343,397 9.8%   
Low Rs1742,560 6.8%   
Sales per share (Unadj.) Rs146.9856.5 17.2%  
Earnings per share (Unadj.) Rs11.978.0 15.3%  
Cash flow per share (Unadj.) Rs16.2139.9 11.6%  
Dividends per share (Unadj.) Rs2.0020.00 10.0%  
Dividend yield (eoy) %0.80.7 117.3%  
Book value per share (Unadj.) Rs105.1739.8 14.2%  
Shares outstanding (eoy) m90.84165.74 54.8%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x1.73.5 49.7%   
Avg P/E ratio x21.438.2 55.9%  
P/CF ratio (eoy) x15.721.3 73.7%  
Price / Book Value ratio x2.44.0 60.0%  
Dividend payout %16.825.7 65.5%   
Avg Mkt Cap Rs m23,073493,632 4.7%   
No. of employees `0005.722.7 25.0%   
Total wages/salary Rs m2,55831,068 8.2%   
Avg. sales/employee Rs Th2,352.56,259.0 37.6%   
Avg. wages/employee Rs Th450.91,369.8 32.9%   
Avg. net profit/employee Rs Th190.4569.7 33.4%   
INCOME DATA
Net Sales Rs m13,346141,961 9.4%  
Other income Rs m1921,715 11.2%   
Total revenues Rs m13,538143,676 9.4%   
Gross profit Rs m1,63924,722 6.6%  
Depreciation Rs m39010,266 3.8%   
Interest Rs m29634 4.5%   
Profit before tax Rs m1,41215,537 9.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-4349 -1.1%   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m2932,965 9.9%   
Profit after tax Rs m1,08012,921 8.4%  
Gross profit margin %12.317.4 70.5%  
Effective tax rate %20.719.1 108.6%   
Net profit margin %8.19.1 88.9%  
BALANCE SHEET DATA
Current assets Rs m5,97996,837 6.2%   
Current liabilities Rs m2,43284,199 2.9%   
Net working cap to sales %26.68.9 298.6%  
Current ratio x2.51.2 213.8%  
Inventory Days Days6373 86.0%  
Debtors Days Days6098 61.8%  
Net fixed assets Rs m6,403102,552 6.2%   
Share capital Rs m182829 21.9%   
"Free" reserves Rs m9,293121,792 7.6%   
Net worth Rs m9,548122,621 7.8%   
Long term debt Rs m2305,449 4.2%   
Total assets Rs m12,843218,165 5.9%  
Interest coverage x50.025.5 196.2%   
Debt to equity ratio x00 54.3%  
Sales to assets ratio x1.00.7 159.7%   
Return on assets %8.66.2 139.0%  
Return on equity %11.310.5 107.4%  
Return on capital %14.312.9 111.1%  
Exports to sales %29.254.6 53.5%   
Imports to sales %6.39.4 67.9%   
Exports (fob) Rs m3,90077,520 5.0%   
Imports (cif) Rs m84713,274 6.4%   
Fx inflow Rs m4,35681,670 5.3%   
Fx outflow Rs m1,16226,355 4.4%   
Net fx Rs m3,19455,315 5.8%   
CASH FLOW
From Operations Rs m1,11921,444 5.2%  
From Investments Rs m-853-18,404 4.6%  
From Financial Activity Rs m-334-3,692 9.1%  
Net Cashflow Rs m-68-1,144 6.0%  

Share Holding

Indian Promoters % 50.1 25.5 196.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 5.4 279.6%  
FIIs % 3.0 35.3 8.5%  
ADR/GDR % 0.0 18.5 -  
Free float % 31.7 15.3 207.2%  
Shareholders   20,176 75,885 26.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   NOVARTIS  TORRENT PHARMA  FRESENIUS KABI ONCO.  STERLING BIOTECH  ASTRAZENECA PHARMA  

Compare UNICHEM LAB With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Flat; Realty Sector Down 2.1%(11:30 am)

Stock markets in India are presently trading on a flattish note. Sectoral indices are trading on a mixed note with stocks in the realty sector and metal sector witnessing maximum selling pressure.

Related Views on News

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 16, 2018 12:47 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS